Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-Stage Healthcare Crossover Fund

Retrieved on: 2021-03-03 04:52:30

Tags for this article:

Click the tags to see associated articles and topics

Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-Stage Healthcare Crossover Fund. View article details on hiswai:

Excerpt

... capital raise positions Sofinnova Partners as the largest crossover investor in Europe dedicated to late-stage biopharma and medtech investments.

Article found on: www.northwestgeorgianews.com